4/A//SEC Filing
Townsend Richard Nolan 4/A
Accession 0001415889-25-024104
CIK 0001907108other
Filed
Sep 9, 8:00 PM ET
Accepted
Sep 10, 4:59 PM ET
Size
5.3 KB
Accession
0001415889-25-024104
Insider Transaction Report
Form 4/AAmended
Townsend Richard Nolan
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
2025-08-18$4.67/sh−1,115$5,205→ 220,058 total
Footnotes (3)
- [F1]Represents a sale to cover tax obligations on the release of restricted stock units ("RSUs").
- [F2]On August 20, 2025, the reporting person filed a Form 4 which inadvertently reported the disposition of 2,735 securities. In fact, as reported in this amendment, the reporting person disposed of 1,115 shares of Common Stock on August 18, 2025.
- [F3]Includes 131,092 Restricted Stock Units.
Documents
Issuer
Lexeo Therapeutics, Inc.
CIK 0001907108
Entity typeother
Related Parties
1- filerCIK 0001995218
Filing Metadata
- Form type
- 4/A
- Filed
- Sep 9, 8:00 PM ET
- Accepted
- Sep 10, 4:59 PM ET
- Size
- 5.3 KB